ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 658837 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 658837; 2) Community: the network communities that were significantly associated with the response to NSC 658837; 3) Molecule: the relationships between components within communities and NSC 658837; 4) MDR: the compounds that were significantly associated with the NSC 658837.

NSC Compound Enrichment Correlation
NSC 673190 Null 0.0212053315848709 0.55298847
NSC 678131 Null 0.0212053315848709 0.12057617
NSC 694234 Null 0.0212053315848709 -0.026536795
NSC 697715 Null 0.0212053315848709 -0.04449686
NSC 723906 1,4-di-N-oxide-6,7-difluor-2-phenylcarbonyl-3-trifluormethyl quinoxaline 0.0212053315848709 0.092171532
NSC 750970 3-[(E)-1-(3-1-[(4-fluorophenyl)sulfonyl]-4-piperidylimidazo[1,5-a]pyridin-1-yl)methylidene]-2-indolinone 0.0212053315848709 -0.03546307
NSC 610744 Imidazole, 1-(4-chlorophenyl)-4-(4-nitrophenyl)- 0.0212053315848711 0.073247973
NSC 65537 Null 0.0212053315848711 0.21248715
NSC 294979 BLEOMYCIN-BAPP 0.0217366743178497 -0.017234809
NSC 348121 4,6-Methano-5H-benz[h]oxazolo[3,2-a]pyrazino-[3,2,1-de][1,5]naphthyridine-7-carbonitrile, 1,2,3a,4,4a,6,7,9,10,13,13b,13c-dodecahydro-9-(hydroxymethyl)-11-methoxy-5,12-dimethyl-10,13-dioxo- 0.0217366743178497 0.28339019
Total:48  Current:20    [First] [Prev] [Next] [Last]